At this stage, neither Toujeo nor GLP-1 medications are typically involved
Wegovy injection or tablets: In patients with diabetes mellitus, monitor blood glucose before starting and during therapy
Baseline assessment before initiating GLP-1 agonist therapy should include: Full blood count to establish baseline haematological parameters Renal and hepatic function tests (note: exenatide is not recommended if eGFR 5% body weight over 3 months should trigger reassessment), or if the medication interferes with cancer treatment adherence
All purchasers and handlers assume responsibility for lawful use, proper storage, and adherence to applicable research, laboratory, and safety standards.
While clinical data does not show increased cancer risk with tesamorelin specifically, the absence of evidence from combination protocols means the risk cannot be quantified
Your travel kit should include: All prescribed GLP-1 pens or vials with sufficient doses Spare needles (if using reusable pens) Alcohol wipes for injection site preparation A sharps container for safe needle disposal Your GP letter and prescription documentation Travel insurance documents confirming medication coverage Contact details for your GP surgery and diabetes specialist team A list of your medications (generic and brand names) in case you need emergency care abroad Keep all GLP-1 medications in your hand luggage to avoid temperature extremes in the aircraft hold
